3652 results for «345»
3652 results
Challenging TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this captivating session that explores challenging TAVI procedures. Witness the management of a patient with pure aortic regurgitation and previous mitral valve replacement, an extremely challenging transfemoral TAVI, the management of bradycardia before TAVI in a patient with MVR and TVR, a case of...
TAV-in-SAV - Part 2
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the second part of the TAV-in-SAV session, where you'll discover the reproducible BASILICA technique using an enface view, chimney stenting during TAV-in-SAV in a high coronary occlusion risk patient, urgent zero contrast TAV-in-SAV, a tale of a complication where you shouldn't BASILICA the new...
Valve in valve in small degenerative surgical bioprosthesis - LIVE case
09 Feb 2025 – From PCR Tokyo Valves 2025
A 74-year-old female with a permanent pacemaker and preserved LV function presented with a symptomatic degenerative surgical valve (SJ Epic 21) implanted in 2016.
Patient underwent implantation of an Evolut FX 26 mm under general anesthesia with cerebral embolic protection and TEE guidance. A surgical valve fracture...
M-TEER for challenging anatomy
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of M-TEER for challenging anatomies. Understand the types of complex anatomies, the associated risks of complications, and learn how to select the appropriate TEER strategy for patients with small left atria, large gaps, and giant left atria. Gain valuable insights to optimize...
TAVI burning issues
09 Feb 2025 – From PCR Tokyo Valves 2025
This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...
Imaging in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in imaging for TAVI, covering a range of topics. Discover insights into clinical outcomes in patients with very low-gradient severe aortic stenosis after TAVI, the influence of TAVI valve differences on long-term outcomes in left ventricular mass index, the...
Valvular interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in valvular interventions in this comprehensive session. Dive into the medical cost analysis of TAVR versus SAVR in Japanese dialysis patients, the long-term outcomes of Myval valve implantation in the pulmonary position, the comparative effectiveness of balloon aortic valvuloplasty techniques,...
Bicuspid and complications
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this comprehensive session exploring the complexities of bicuspid aortic valve disease and the associated complications. Discover tailored sizing techniques for balloon-expandable valves in type 1 bicuspid, navigate the challenges of TAVR in bicuspid aortic valve type 0 with small annulus and coronary compromise, and...
PCR London Valves 2021 – Welcome message
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
Real-world outcomes with the PASCAL Platform in TR
03 Dec 2021
The PASCAL platform, comprising the PASCAL and PASCAL Ace implants, received its CE mark for TR in May 2020 and has been shown to be an effective and safe treatment option for patients with TR.3,4,6 Professor Jörg Hausleiter and Dr Mirjam Wild now describe their single-centre experience...
One-year results of the Clasp TR Study: Transcatheter treatment of tricuspid regurgitation
22 Mar 2022
Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.
Author
Author
